First Quadrant’s QIAGEN NV QGENF Stock Holding History

First Quadrant’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,500	Closed	-$182K	–	893
2016 Q4	$182K	Hold	6,500	–	–	﹤0.01%	649
2016 Q3	$178K	Hold	6,500	–	–	﹤0.01%	661
2016 Q2	$142K	Hold	6,500	–	–	﹤0.01%	616
2016 Q1	$145K	Buy	+6,500	New	+$145K	﹤0.01%	610
2015 Q4	–	Sell	-232,200	Closed	-$5.99M	–	892
2015 Q3	$5.99M	Buy	+232,200	New	+$5.99M	0.13%	188

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

First Quadrant's QGENF Position: Q1 2017 in Review

First Quadrant sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 6,500 shares — an estimated $182K sold.

First Quadrant first reported a position in QGENF in Q3 2015 and held it in 5 quarters. The position peaked at $5.99M in Q3 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

First Quadrant reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
First Quadrant sold 6,500 QIAGEN NV shares in Q1 2017, an estimated $182K.
First Quadrant first reported a position in QIAGEN NV in Q3 2015 and held it in 5 quarters.
First Quadrant's QIAGEN NV position peaked at $5.99M in Q3 2015.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on First Quadrant's 13F filing for Q1 2017, filed 25 Apr 2017.